Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations.
D000166:Acridines / Q000494:pharmacology*; D000328:Adult; D001519:Behavior / Q000187:drug effects*; D002540:Cerebral Cortex / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003693:Delirium / Q000139:chemically induced; D004336:Drug Antagonism; D004562:Electrocardiography; D004569:Electroencephalography; D004576:Electromyography; D005133:Eye Movements / Q000187:drug effects; D005260:Female; D006213:Hallucinogens / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects; D015016:Yohimbine / Q000494:pharmacology
D000166:Acridines; D006213:Hallucinogens; D015016:Yohimbine; D009388:Neostigmine; D008238:Lysergic Acid Diethylamide; D011395:Promazine; D002746:Chlorpromazine